CN106942560A - It is a kind of rich in the moving solid drink formula of protein peptides and its production procedure - Google Patents
It is a kind of rich in the moving solid drink formula of protein peptides and its production procedure Download PDFInfo
- Publication number
- CN106942560A CN106942560A CN201710208019.9A CN201710208019A CN106942560A CN 106942560 A CN106942560 A CN 106942560A CN 201710208019 A CN201710208019 A CN 201710208019A CN 106942560 A CN106942560 A CN 106942560A
- Authority
- CN
- China
- Prior art keywords
- parts
- protein peptides
- rich
- vitamin
- production procedure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 26
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 26
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 25
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 24
- 239000007787 solid Substances 0.000 title claims abstract description 14
- 238000000034 method Methods 0.000 title claims abstract description 13
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 11
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 21
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims abstract description 7
- 239000001527 calcium lactate Substances 0.000 claims abstract description 7
- 229960002401 calcium lactate Drugs 0.000 claims abstract description 7
- 235000011086 calcium lactate Nutrition 0.000 claims abstract description 7
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims abstract description 7
- 239000001095 magnesium carbonate Substances 0.000 claims abstract description 7
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims abstract description 7
- 235000019799 monosodium phosphate Nutrition 0.000 claims abstract description 7
- 229910000403 monosodium phosphate Inorganic materials 0.000 claims abstract description 7
- 239000001508 potassium citrate Substances 0.000 claims abstract description 7
- 229960002635 potassium citrate Drugs 0.000 claims abstract description 7
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 claims abstract description 7
- 235000011082 potassium citrates Nutrition 0.000 claims abstract description 7
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims abstract description 7
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims abstract description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 5
- 229960005070 ascorbic acid Drugs 0.000 claims abstract description 5
- 239000000463 material Substances 0.000 claims description 11
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 9
- 238000012545 processing Methods 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 235000013361 beverage Nutrition 0.000 claims description 8
- 239000008101 lactose Substances 0.000 claims description 8
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims description 6
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 claims description 6
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 6
- 229930003451 Vitamin B1 Natural products 0.000 claims description 6
- 238000001514 detection method Methods 0.000 claims description 6
- 229960000367 inositol Drugs 0.000 claims description 6
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 6
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 6
- 229940083466 soybean lecithin Drugs 0.000 claims description 6
- 229960003495 thiamine Drugs 0.000 claims description 6
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 6
- 239000011691 vitamin B1 Substances 0.000 claims description 6
- 235000010374 vitamin B1 Nutrition 0.000 claims description 6
- 239000005913 Maltodextrin Substances 0.000 claims description 5
- 229920002774 Maltodextrin Polymers 0.000 claims description 5
- 150000005693 branched-chain amino acids Chemical class 0.000 claims description 5
- 235000021552 granulated sugar Nutrition 0.000 claims description 5
- 229940035034 maltodextrin Drugs 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 4
- 239000005862 Whey Substances 0.000 claims description 3
- 102000007544 Whey Proteins Human genes 0.000 claims description 3
- 108010046377 Whey Proteins Proteins 0.000 claims description 3
- 230000001580 bacterial effect Effects 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 239000012530 fluid Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000012528 membrane Substances 0.000 claims description 3
- 229910052751 metal Inorganic materials 0.000 claims description 3
- 239000002184 metal Substances 0.000 claims description 3
- 244000000010 microbial pathogen Species 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 238000012858 packaging process Methods 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 238000001556 precipitation Methods 0.000 claims description 3
- 229910052761 rare earth metal Inorganic materials 0.000 claims description 3
- 150000002910 rare earth metals Chemical class 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 3
- 238000000108 ultra-filtration Methods 0.000 claims description 3
- 239000011785 micronutrient Substances 0.000 claims description 2
- 235000013369 micronutrients Nutrition 0.000 claims description 2
- 229940088594 vitamin Drugs 0.000 claims description 2
- 235000013343 vitamin Nutrition 0.000 claims description 2
- 239000011782 vitamin Substances 0.000 claims description 2
- 229930003231 vitamin Natural products 0.000 claims description 2
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims 2
- 229910000619 316 stainless steel Inorganic materials 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 229910021529 ammonia Inorganic materials 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 abstract description 6
- 238000003786 synthesis reaction Methods 0.000 abstract description 5
- 238000011084 recovery Methods 0.000 abstract description 4
- 238000012549 training Methods 0.000 abstract description 4
- 238000005516 engineering process Methods 0.000 abstract description 3
- 235000011496 sports drink Nutrition 0.000 abstract description 3
- 230000033228 biological regulation Effects 0.000 abstract description 2
- 210000005056 cell body Anatomy 0.000 abstract description 2
- 239000000835 fiber Substances 0.000 abstract description 2
- 235000013372 meat Nutrition 0.000 abstract description 2
- 230000008439 repair process Effects 0.000 abstract description 2
- 101150088952 IGF1 gene Proteins 0.000 abstract 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 12
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 12
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 12
- 230000000694 effects Effects 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 238000011161 development Methods 0.000 description 7
- 230000018109 developmental process Effects 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 230000006870 function Effects 0.000 description 6
- 229960003604 testosterone Drugs 0.000 description 6
- 108010054147 Hemoglobins Proteins 0.000 description 5
- 102000001554 Hemoglobins Human genes 0.000 description 5
- 230000003321 amplification Effects 0.000 description 5
- 238000003199 nucleic acid amplification method Methods 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 229920002527 Glycogen Polymers 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000024245 cell differentiation Effects 0.000 description 3
- 229940096919 glycogen Drugs 0.000 description 3
- 102000002734 Collagen Type VI Human genes 0.000 description 2
- 108010043741 Collagen Type VI Proteins 0.000 description 2
- 102000004420 Creatine Kinase Human genes 0.000 description 2
- 108010042126 Creatine kinase Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 102000055008 Matrilin Proteins Human genes 0.000 description 2
- 108010072582 Matrilin Proteins Proteins 0.000 description 2
- 229910000831 Steel Inorganic materials 0.000 description 2
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000004130 lipolysis Effects 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 239000010959 steel Substances 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- 229940124549 vasodilator Drugs 0.000 description 2
- 239000003071 vasodilator agent Substances 0.000 description 2
- 102100030840 AT-rich interactive domain-containing protein 4B Human genes 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 101000792935 Homo sapiens AT-rich interactive domain-containing protein 4B Proteins 0.000 description 1
- 101000976075 Homo sapiens Insulin Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009858 acid secretion Effects 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003305 autocrine Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 210000003321 cartilage cell Anatomy 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 235000015897 energy drink Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000020510 functional beverage Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229940091250 magnesium supplement Drugs 0.000 description 1
- 239000003226 mitogen Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 210000003360 nephrocyte Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000003076 paracrine Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940083542 sodium Drugs 0.000 description 1
- 210000004988 splenocyte Anatomy 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 108010002139 very low density lipoprotein triglyceride Proteins 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 230000037314 wound repair Effects 0.000 description 1
- 229920001221 xylan Polymers 0.000 description 1
- 150000004823 xylans Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Non-Alcoholic Beverages (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The present invention relates to a kind of rich in the moving solid drink formula of protein peptides and its production procedure, belong to technical field of functional drink；34 parts of xylo-oligosaccharide, 68 parts of FOS, protein peptides（IGF 1) 68 parts, 0.6 0.8 parts of calcium lactate, 0.5 0.7 parts of magnesium carbonate, 0.5 0.8 parts of citric acid, 13 parts of potassium citrate, 0.8 1 parts of sodium dihydrogen phosphate, 0.3 0.35 parts of vitamin c；Its rational technology, makes simple, meets the indices regulation of sports drink, and helpful to the fitness of sportsman, is conducive to sportsman quickly to regain one's strength;The main professional or professional endurance type sportsman and sports enthusiast for being applicable high pressure training, for fast quick-recovery physical efficiency, repairs meat fiber, promotes soma synthesis.
Description
Technical field
The present invention relates to a kind of rich in the moving solid drink formula of protein peptides and its production procedure, belong to drinks skill
Art field.
Background technology
Drinks refer to the composition and content ratio by adjusting nutrient in beverage, and human body is adjusted to a certain extent
The beverage of function.Classification according to relevant information to functional beverage, it is believed that the drinks of broad sense include sports drink, energy and drunk
Material has the beverage of health-care effect with other.Drinks are that fashionable one kind in developed countries such as American-European and Japan is good for over 2000
Kang Yinpin.It contains the electrolyte such as potassium, sodium, calcium, magnesium, and composition is similar to human body fluid, can be more absorbed by the body rapidly after drinking,
Supplement human body makes body fluid reach poised state because of a large amount of motion perspirations lost moisture and electrolyte (salinity) in time.
China's drinks market prospects are mainly reflected in three aspects：First, compared with World Developed Countries, China's drinks
Consumption per head be only 0.5 kilogram every year, apart from the whole world, 7 kilograms of consumption figure still has larger space per capita, it means that
There is huge development space in China's drinks;2nd, with drinks market further improve and professional standard rule
Generalized, the development environment in China's drinks market will be further improved, and this will send out for the health of China's drinks
Good development space is created in exhibition;3rd, in recent years, with the consumption of the continuous improvement of consumption of resident ability, especially residents from villages and towns
The lifting of ability, future feature beverage will be endowed the concept of more healthy functions, and this will be provided by force for the development of drinks
Strength power.
Problem of both being primarily present in development of current drinks：First, the market concentration is than relatively low, with new
The release of product and the further raising for dynamics of marketing, the market concentration and competitive level of drinks will get a promotion；2nd,
Local brand builds not perfect enough, and the development of drinks be unable to do without the sound development of drinks product brand, to native country work(
For energy drink enterprise, the construction of product brand shoulders heavy responsibilities.
The content of the invention
It is an object of the invention to the defect for prior art and not enough simple there is provided a kind of technique, it is reasonable in design plus
Work is easily rich in moving solid drink formula and its production procedure of protein peptides.
To achieve the above object, the technical solution adopted by the present invention is：It is prepared from by the raw material of following weight point：It is low
3-4 parts of xylan, 6-8 parts of FOS, protein peptides（IGF-1) 6-8 parts, 0.6-0.8 parts of calcium lactate, 0.5-0.7 parts of magnesium carbonate,
0.5-0.8 parts of citric acid, 1-3 parts of potassium citrate, 0.8-1 parts of sodium dihydrogen phosphate, 0.3-0.35 parts of vitamin c, vitamin B1,
B2, B6, B120.3-0.4 parts, 2-3 parts of maltodextrin, 0.2-0.5 parts of inositol, 10-15 parts of white granulated sugar, branched-chain amino acid（BCAA）
0.6-0.8 parts, 0.5-1.5 parts of other micro-nutrient compositions.
The production procedure of the moving solid beverage rich in protein peptides is comprised the steps of：
1st, pasteurize processing is carried out, after pasteurize processing, product controls bacterial number within 5 working days and kills all
Pathogenic microorganism；
2nd, using milipore filter water plus lactose（3-4 parts of xylo-oligosaccharide, 6-8 parts of FOS）Separated from whey, make dry
Middle protein content reaches 34%；
3rd, using ultrafiltration membrance filter water plus lactose, protein content in dry is made to reach 80%；
4th, using nanometer water separating membrane and lactose, increase solids content, add 6-8 parts of separation protein peptides and calcium lactate 0.6-0.8
Part, 0.5-0.7 parts of magnesium carbonate, 0.5-0.8 parts of citric acid, 1-3 parts of potassium citrate, 0.8-1 parts of sodium dihydrogen phosphate, vitamin
C0.3-0.35 parts, vitamin B1, B2, B6, B120.3-0.4 parts, 2-3 parts of maltodextrin, 0.2-0.5 parts of inositol, white granulated sugar 10-
15 parts, 0.6-0.8 parts of branched-chain amino acid；
5th, the material in step 4 is sufficiently mixed, 80% concentrate is stored in the environment less than seven degree before it is dried after precipitation
24 hours or so；
6th, processing material is dried, product is directly changed into powder by liquid, and adds highly refined in fluid bed
Soybean lecithin；Highly refined soybean lecithin is added in fluidized bed drying process makes its content reach 1%
7th, by rare-earth magnet detection and metal detection, non-ferrous no more than 2.5 millimeters, ferrous iron is no more than 2.0 millimeters, and 316 are not
The steel that becomes rusty is no more than 3.0mm；
8th, packaging bag is that FDA/USDA ratifies material, is then placed in warehouse storage, and packaging process is all complete at more than 31 degree Celsius
Into.
Protein peptides English name IGF-1, also known as human growth factor, are a kind of activated protein peptide materials, and it is in human body
The product of several cell autocrines of liver cell, nephrocyte, splenocyte etc. ten and paracrine（That is inherently contain in human body
IGF-1）.Its concrete function is as follows：
A. it is hypoglycemic：IGF-1 is similar to insulin in this respect, can strengthen the absorption to glucose and amino acid, promotes glycogen
Synthesis and Lactic Acid Secretion, suppress decomposition of glycogen, increase human body improves the work of human insulin to the function of insulin sensitivity
Use efficiency.To Non-insulin-dependent diabetes mellitus（Type ii diabetes）With preferable curative effect.
B. reducing blood lipid：IGF-1, which acts on fat cell, can promote total glycerine three in lipolysis and Glycogen synthesis, reduction blood
The level of ester, very low density lipoprotein triglyceride and LDL-C.（Document confirms not influence lipolysis）
C. vasodilator：IGF-1 can adjust the physiology and pathological condition of heart, with vasodilator, reduce vascular resistence, increase
The effect of the CBF of heart.
D. the anabolism of bone is promoted to keep its normal configuration function：IGF-1 can significantly facilitate the cartilage in a variety of sources
The synthesis of cell division propagation and cartilage matrix.IGF-1 can also stimulate cartilage cell to synthesize the special Collagen Type VI egg of cartilage matrix
- II Collagen Type VIs, increase the activity of the poly- enzyme of osamine in vain, strengthen the activity of the alkaline phosphatase of Gegenbaur's cell.
E. growth promotion：IGF-1 is very important cell mitogen accelerator in human body（It is Specifically certain dense
Spend scope）.
F promotees cell differentiation：IGF-1 to maintaining relevant with cell differentiation protein level particularly significant, with some grow because
Son, which is shared, can promote cell differentiation ripe.7. wound repair：IGF-1 also participates in the process of wound healing.It is demonstrated experimentally that damage
IGF-1 concentration increase in nerve, muscle and endothelial cells.
After said structure, the present invention has the beneficial effect that：A kind of moving solid rich in protein peptides of the present invention
Drink formula and its production procedure, rational technology make simple, meet the indices regulation of sports drink, and to sportsman
Fitness it is helpful, be conducive to sportsman quickly to regain one's strength;Mainly it is applicable the professional or professional resistance to of high pressure training
Power type sportsman and sports enthusiast, for fast quick-recovery physical efficiency, repair meat fiber, promote soma synthesis.
Embodiment
It is made up of in the present invention in the dispensing of 50g packing units the raw material of following weight parts：Xylo-oligosaccharide 5g, FOS
10g, protein peptides 10g, calcium lactate 1g, magnesium carbonate 1g, citric acid 1g, potassium citrate 2g, sodium dihydrogen phosphate 1g, vitamin B1, B2,
B6, B12 common 500mg, vitamin c 50mg, maltodextrin 5g, inositol 50mg, branched-chain amino acid 1g, flavorant.
The production procedure of the moving solid beverage rich in protein peptides is comprised the steps of：
1st, pasteurize processing is carried out, after pasteurize processing, product controls bacterial number within 5 working days and kills all
Pathogenic microorganism；
2nd, using milipore filter water plus lactose, xylo-oligosaccharide 5g, FOS 10g separate from whey, make albumen in dry
Content reaches 34%；
3rd, using ultrafiltration membrance filter water plus lactose, protein content in dry is made to reach 80%；
4th, using nanometer water separating membrane and lactose, increase solids content, add separation protein peptides 10g, calcium lactate 1g, magnesium carbonate
1g, citric acid 1g, potassium citrate 2g, sodium dihydrogen phosphate 1g, vitamin B1, B2, B6, B12 common 500mg, vitamin c 50mg, wheat
Bud dextrin 5g, inositol 50mg, branched-chain amino acid 1g, flavorant, not enough uses granulated sugar；
5th, the material in step 4 is sufficiently mixed, 80% concentrate is stored in the environment less than seven degree before it is dried after precipitation
24 hours or so；
6th, processing material is dried, product is directly changed into powder by liquid, and adds highly refined in fluid bed
Soybean lecithin；Highly refined soybean lecithin is added in fluidized bed drying process makes its content reach 1%
7th, by rare-earth magnet detection and metal detection, non-ferrous no more than 2.5 millimeters, ferrous iron is no more than 2.0 millimeters, and 316 are not
The steel that becomes rusty is no more than 3.0mm；
8th, packaging bag is that FDA/USDA ratifies material, is then placed in warehouse storage, and packaging process is all complete at more than 31 degree Celsius
Into.
Embodiment：
Referring to table one：4 people are divided into two groups, if experimental group and control group.According to the characteristics of this project, belong to the competing of resistance to Lixing
Fast project, main function be testosterone and hemoglobin level, and heavy training complete recovery level, so experimental group take
With protein peptides 21 days, four contrast tests are carried out, test machine energy is inside had（Including hemoglobin, testosterone, blood urea nitrogen, creatine
Kinases）, general quality（100m and standing long jump）, special quality（1500m）.
Test data analyzer：
A, experimental group and control group serum testosterone contrast situation.
After 15 days take, the experimental result with BMX is basically identical, and serum testosterone rise trend is notable.With this
Meanwhile, protein peptides synthetic is also examined in this experiment delays effect after deactivation, by the machine for disabling one week after
The trend for finding that sportswoman's serum testosterone still has rising can be tested, sportsman then occurs in that fluctuation.During taking
Sportswoman's amplification is respectively 82%, 129%, and the amplification of sportsman is respectively 49%, 143%.The reason for amplification is very notable, it is comprehensive
Conjunction may determine that to the tracking and testing of blood urea nitrogen and creatine kinase stimulate not enough for training load, along with protein peptides are supplemented,
Amplification is very significantly just not at all surprising.
B, experimental group and contrast groups hemoglobin（It is commonly called as hemochrome）Contrast situation.
From the point of view of test number, experimental group sportsman fluctuation is larger, and main cause is that the change of hemoglobin typically exists
Within 24-72 hours, take amplification at initial stage significantly, hereafter decline, rear and slow rising, until disabling one week after.
The serum testosterone and hemoglobin of control group are from the point of view of the numerical value of test without obvious variation tendency.
In a word, by testing verified certain effect significantly, for having substantially with postexercise recovery in high intensity exercise
Help, can be used for the contest demand of a line sportsman, the effect of protein peptides is fairly obvious, is mainly manifested in：Improve sportsman
Functional state, resume speed, the local cold weather particularly during taking, the different appearance of sportsman's degree for not taking
The illness of cold, but four people taken the symptom without flu, so protein peptides synthetic beverage has sick and wounded to preventing
Facilitation.
The above, is merely illustrative of the technical solution of the present invention and unrestricted, those of ordinary skill in the art are to this hair
Other modifications or equivalent that bright technical scheme is made, without departing from the spirit and scope of technical solution of the present invention,
It all should cover among scope of the presently claimed invention.
Table one.
Claims (2)
1. it is a kind of rich in the moving solid drink formula of protein peptides and its production procedure, it is characterised in that：It is by following weight point
Raw material be prepared from：3-4 parts of xylo-oligosaccharide, 6-8 parts of FOS, 6-8 parts of protein peptides, 0.6-0.8 parts of calcium lactate, magnesium carbonate
0.5-0.7 parts, 0.5-0.8 parts of citric acid, 1-3 parts of potassium citrate, 0.8-1 parts of sodium dihydrogen phosphate, 0.3-0.35 parts of vitamin c,
Vitamin B1, B2, B6, B120.3-0.4 parts, 2-3 parts of maltodextrin, 0.2-0.5 parts of inositol, 10-15 parts of white granulated sugar, side chain ammonia
0.6-0.8 parts of base acid, 0.5-1.5 parts of other micro-nutrient compositions.
2. it is according to claim 1 a kind of rich in the moving solid drink formula of protein peptides and its production procedure, its feature
It is：
The production procedure of the moving solid beverage rich in protein peptides is comprised the steps of：
(1) pasteurize processing, is carried out, after pasteurize processing, product controls bacterial number within 5 working days and kills institute
Some pathogenic microorganisms；
(2), using milipore filter water plus lactose, 3-4 parts of xylo-oligosaccharide, 6-8 parts of FOS separate from whey, make dry
Protein content reaches 34% in matter；
(3), using ultrafiltration membrance filter water plus lactose, protein content in dry is made to reach 80%；
(4), using nanometer water separating membrane and lactose, increase solids content, add 6-8 parts of separation protein peptides and calcium lactate 0.6-
0.8 part, 0.5-0.7 parts of magnesium carbonate, 0.5-0.8 parts of citric acid, 1-3 parts of potassium citrate, 0.8-1 parts of sodium dihydrogen phosphate, vitamin
C0.3-0.35 parts, vitamin B1, B2, B6, B120.3-0.4 parts, 2-3 parts of maltodextrin, 0.2-0.5 parts of inositol, white granulated sugar 10-
15 parts, 0.6-0.8 parts of branched-chain amino acid；
(5), the material in step (4) is sufficiently mixed, 80% concentrate is stored in the ring less than seven degree before it is dried after precipitation
24 hours or so in border；
(6), material is dried processing, product is directly changed into powder by liquid, and adds highly refined in fluid bed
Soybean lecithin；Highly refined soybean lecithin is added in fluidized bed drying process makes its content reach 1%;
(7), by rare-earth magnet detection and metal detection, non-ferrous no more than 2.5 millimeters, ferrous iron is no more than 2.0 millimeters, 316
Stainless steel is no more than 3.0mm；
(8), packaging bag is that FDA/USDA ratifies material, is then placed in warehouse storage, packaging process is all at more than 31 degree Celsius
Complete.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710208019.9A CN106942560A (en) | 2017-03-31 | 2017-03-31 | It is a kind of rich in the moving solid drink formula of protein peptides and its production procedure |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710208019.9A CN106942560A (en) | 2017-03-31 | 2017-03-31 | It is a kind of rich in the moving solid drink formula of protein peptides and its production procedure |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106942560A true CN106942560A (en) | 2017-07-14 |
Family
ID=59473980
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710208019.9A Pending CN106942560A (en) | 2017-03-31 | 2017-03-31 | It is a kind of rich in the moving solid drink formula of protein peptides and its production procedure |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106942560A (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1692836A (en) * | 2005-06-16 | 2005-11-09 | 欧阳康乐 | Multiple elements solid beverage for quickly supplementing energy and nutrition |
| CN103518843A (en) * | 2013-10-20 | 2014-01-22 | 丹阳市正大油脂有限公司 | Soybean peptide solid beverage |
| CN105054210A (en) * | 2015-09-06 | 2015-11-18 | 王乾 | A multiple-energy solid beverage |
| CN105341614A (en) * | 2015-12-17 | 2016-02-24 | 重庆都好生物科技有限公司 | Small molecule peptide solid drink |
| CN105495262A (en) * | 2015-12-17 | 2016-04-20 | 重庆都好生物科技有限公司 | Double-protein-peptide anti-fatigue solid beverage |
| CN106259946A (en) * | 2016-08-23 | 2017-01-04 | 江苏朸健生命科技发展有限公司 | A kind of sport nutrition solid beverage and preparation method thereof |
-
2017
- 2017-03-31 CN CN201710208019.9A patent/CN106942560A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1692836A (en) * | 2005-06-16 | 2005-11-09 | 欧阳康乐 | Multiple elements solid beverage for quickly supplementing energy and nutrition |
| CN103518843A (en) * | 2013-10-20 | 2014-01-22 | 丹阳市正大油脂有限公司 | Soybean peptide solid beverage |
| CN105054210A (en) * | 2015-09-06 | 2015-11-18 | 王乾 | A multiple-energy solid beverage |
| CN105341614A (en) * | 2015-12-17 | 2016-02-24 | 重庆都好生物科技有限公司 | Small molecule peptide solid drink |
| CN105495262A (en) * | 2015-12-17 | 2016-04-20 | 重庆都好生物科技有限公司 | Double-protein-peptide anti-fatigue solid beverage |
| CN106259946A (en) * | 2016-08-23 | 2017-01-04 | 江苏朸健生命科技发展有限公司 | A kind of sport nutrition solid beverage and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1321589C (en) | Soy-bean peptide | |
| CN100502692C (en) | Physical recovery healthy food and preparation process thereof | |
| CN102823800B (en) | Polypeptide nutritional health-care food containing marine fish oligopeptides | |
| CN1076183C (en) | New beverage | |
| CN108651998A (en) | It is a kind of have relieve fatigue PURE WHEY of function and preparation method thereof | |
| CN105495262A (en) | Double-protein-peptide anti-fatigue solid beverage | |
| CN108703249A (en) | A kind of collagen product and preparation method thereof | |
| CN108606327A (en) | It is a kind of that there is the alimentation composition and preparation method thereof for increasing flesh effect | |
| Ronghui | The reasearch on the anti-fatigue effect of whey protein powder in basketball training | |
| CN107259586A (en) | It is a kind of to be suitable to continue the nutritional supplementation powder that weight intense physical exercises crowd eats | |
| CN107712064A (en) | A kind of formula peptide milk powder with whitening function of reducing weight and preparation method thereof | |
| CN109757733A (en) | A kind of oral polypeptide powder and its preparation method and application | |
| CN105614228A (en) | Chenopodium quinoa willd multi-vitamin nutrition powder processing method | |
| Alimoradi et al. | Whey proteins: Health benefits and food applications | |
| Obeagu et al. | An Upadte on Interleukin 6 And Iron Status of Volleyball Players | |
| CN105285634B (en) | A kind of training proposes acting type natural function potus composition and its application | |
| CN110393241A (en) | A kind of man-made feeds for taking into account Nibea coibor air bladder quality and oxidation resistance | |
| CN101461550B (en) | Spirulina tablet for student and preparation method thereof | |
| CN107712065A (en) | A kind of person in middle and old age are formulated peptide milk powder and preparation method thereof | |
| CN106418067A (en) | Health beverage capable of replenishing physical power and relieving fatigue | |
| CN106942560A (en) | It is a kind of rich in the moving solid drink formula of protein peptides and its production procedure | |
| CN111449247A (en) | Tumor patient sea cucumber peptide nutritional supplement and processing method thereof | |
| CN106942394A (en) | A kind of concentrated type lactalbumin drink formula and its production procedure | |
| CN105166905A (en) | Compound weight-reducing powder and preparation method thereof | |
| CN106472670A (en) | A kind of sport nutrition type acidified milk and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170714 |
|
| RJ01 | Rejection of invention patent application after publication |